Pharmaceutical industry on recovery track

Published: 2003-12-01 07:00:00

Updated: 2003-12-01 07:00:00

Amid deepened business slump, overall pharmaceutical business condition has improved after the third quarter of this year and leading domestic pharmaceutical firms are grappling with their lackluster sales via aggressive marketing of flagship products and new drug launchings.

Pharmaceutical business sources said that some listed pharmaceutical firms whose fiscal year closed December is fore...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.